Table 3.
Downregulated genes following 48 h EPO treatment of SH-SY5Y cells.
| Genes | Description | Fold change | p value |
|---|---|---|---|
| FOS | FBJ murine osteosarcoma viral oncogene homolog | 0.172 | 7.6E-03 |
| TAGLN | Transgelin | 0.227 | 6.3E-04 |
| IL13RA2 | Interleukin 13 receptor, alpha 2 | 0.344 | 1.9E-03 |
| FOSB | FBJ murine osteosarcoma viral oncogene homolog B | 0.344 | 7.2E-02 |
| PRSS23 | Protease, serine, 23 | 0.362 | 3.5E-03 |
| MME | Membrane metallo-endopeptidase | 0.382 | 5.5E-04 |
| LRRC17 | Leucine rich repeat containing 17 | 0.41 | 6.3E-03 |
| S100A10 | S100 calcium-binding protein A10 | 0.425 | 2.9E-04 |
| TSPAN8 | Tetraspanin 8 | 0.439 | 6.0E-03 |
| EGR1 | Early growth response 1 | 0.443 | 5.2E-02 |
| TP53I3 | Tumor protein p53 inducible protein 3 | 0.446 | 3.0E-04 |
| GPNMB | Glycoprotein (transmembrane) nmb | 0.448 | 6.3E-03 |
| SPARC | Secreted protein, acidic, cysteine-rich | 0.455 | 8.9E-05 |
| COL3A1 | Collagen, type III, alpha 1 | 0.457 | 1.2E-03 |
| OLFML3 | Olfactomedin-like 3 | 0.461 | 2.8E-03 |
| AHNAK | AHNAK nucleoprotein | 0.467 | 1.1E-04 |
| IFITM3 | interferon induced transmembrane protein 3 | 0.468 | 1.7E-04 |
| HTRA1 | HtrA serine peptidase 1 | 0.476 | 1.7E-03 |
| MATN2 | Matrilin 2 | 0.476 | 1.7E-02 |
| COL5A2 | Collagen, type V, alpha | 0.489 | 4.5E-03 |
| IFITM2 | Interferon induced transmembrane protein 2 | 0.491 | 8.8E-04 |
| MGP | Matrix Gla Protein | 0.492 | 4.1E-04 |
| S100A13 | S100 calcium-binding protein A13 | 0.495 | 7.5E-02 |